Search
for

    Glossary Ustekinumab

    monoclonal antibody treating autoimmune diseases by targeting interleukins

    Ustekinumab, marketed as Stelara, is a monoclonal antibody used to treat autoimmune conditions such as psoriasis, psoriatic arthritis, and Crohn's disease. It works by targeting specific proteins in the immune system (interleukin-12 and interleukin-23) to reduce inflammation and abnormal immune responses.

    Sort by

    Research 30 of 273

    1. Response to ustekinumab in three pediatric patients with alopecia areata Pediatric dermatology · 2018 · 25 citations
    2. Effective use of ustekinumab in a patient with concomitant psoriasis, vitiligo, and alopecia areata JAAD case reports · 2017 · 20 citations
    3. Onset of frontal fibrosing alopecia during inhibition of Th1/17 Pathways with ustekinumab Dermatology Online Journal · 2019 · 7 citations
    4. Challenging Regional Psoriasis and Ustekinumab Biotherapy: Impact of the Patterns of Disease Journal of Biomedicine and Biotechnology · 2012 · 6 citations
    5. Comparative Effects of Ustekinumab and Vedolizumab on Alopecia in Ulcerative Colitis: A Systematic Review and Meta-Analysis Journal of Pharmaceutical Research International · 2025
    6. Impact of ustekinumab on quality of life and sexual difficulties associated with psoriasis: Results from phase III clinical trials Journal of The American Academy of Dermatology · 2010
    7. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment Gut · 2013 · 278 citations
    8. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations Journal of the American Academy of Dermatology · 2019 · 256 citations
    9. Primary cicatricial alopecia Journal of The American Academy of Dermatology · 2016 · 95 citations
    10. The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm Advances in Therapy · 2017 · 77 citations
    11. Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism The Journal of Allergy and Clinical Immunology · 2015 · 68 citations
    12. Hair and Scalp Changes in Cutaneous and Systemic Lupus Erythematosus American Journal of Clinical Dermatology · 2018 · 46 citations
    13. Poster Presentations Australasian Journal of Dermatology · 2021 · 25 citations
    14. New developments in the molecular treatment of ichthyosis: review of the literature Orphanet journal of rare diseases · 2022 · 21 citations
    15. IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans 2019 · 20 citations
    16. Learning From Success and Failure: Biologics for Non-approved Skin Diseases Frontiers in immunology · 2019 · 20 citations
    17. Severe Infliximab-Induced Alopecia and Scalp Psoriasis in a Woman with Crohn’s Disease: Dramatic Improvement after Drug Discontinuation and Treatment with Adjuvant Systemic and Topical Therapies Dermatology and therapy · 2016 · 19 citations
    18. Cutaneous Manifestations in Biological-Treated Inflammatory Bowel Disease Patients: A Narrative Review Journal of clinical medicine · 2021 · 15 citations
    19. Successful treatment of concomitant alopecia universalis and Crohn’s disease with upadacitinib: A case report SAGE Open Medical Case Reports · 2023 · 10 citations
    20. TNF inhibitor induced alopecia: an unusual form of psoriasiform alopecia that breaks the Renbök mold Dermatology Online Journal · 2017 · 9 citations
    21. Janus Kinase Inhibitors against Other Biological Treatments in Alopecia Areata Scandinavian journal of immunology · 2016 · 6 citations
    22. Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives Psoriasis : Targets and Therapy · 2020 · 4 citations
    23. TNF-α Inhibitor-Induced Psoriasis and Psoriatic Alopecia in Adolescent with Ulcerative Colitis: Clinical Case Вопросы современной педиатрии · 2023 · 3 citations
    24. Alopecia areata as an immune-related adverse event associated with response to immune checkpoint inhibitors European Journal of Dermatology · 2022 · 3 citations
    25. Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events Biologics · 2025 · 2 citations
    26. Dupilumab for alopecia areata treatment: A double‐edged sword? Journal of cosmetic dermatology · 2022 · 2 citations
    27. A Case of Steatocystoma Multiplex in a Psoriatic Patient during Treatment with Anti-IL-12/23 Skin Appendage Disorders · 2020 · 2 citations
    28. P368 Rare skin disorders in IBD patients treated with anti-TNFs Journal of Crohn's and colitis · 2014 · 2 citations
    29. Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review Indian Dermatology Online Journal · 2024 · 1 citations
    30. S3909 Paradoxical Psoriasis and Alopecia Areata After the Use of Anti-TNF in a Patient With Crohn's Cisease The American Journal of Gastroenterology · 2024 · 1 citations